Skip to main content
SpringerLink
Log in

Pathology of Pulmonary Heart Disease

  • Chapter
Pulmonary Heart Disease

Abstract

A discussion of the pathology of pulmonary heart disease must be centered on the pulmonary vasculature since, in the disease processes relevant to this chapter, the heart is an innocent bystander to events taking place in the lungs. Frequently, the cardiac changes are important and in many cases may constitute the dominant clinical findings. But, the lungs, and the pulmonary vasculature in particular, are where the most prominent pathologic changes usually reside. These changes may be intrinsic to the lung, such as in primary pulmonary hypertension, or secondary to abnormalities in other parts of the body, as in peripheral venous thrombosis with pulmonary thromboembolic disease. Exceptions to this generalization might be congenital heart disease or ischemic heart disease with chronic left ventricular failure, in which the main problem is intrinsic to the heart. These conditions may undoubtedly be associated with pulmonary vascular overload, right ventricular hypertrophy, and right ventricular failure; however, these intrinsic cardiac problems are not ordinarily included in definitions of pulmonary heart disease, or, as it is more commonly known, cor pulmonale (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. World Health Organization. Chronic cor pulmonale. Report of an expert committee of the World Health Organization. Circulation 27: 594–615, 1963.

    Google Scholar 

  2. Fishman AP. Chronic cor pulmonale. Am Rev Revoir Dis 114: 775–794. 1976.

    CAS  Google Scholar 

  3. Wagenvoort CA, Wagenvoort N. Pathology of Pulmonary Hypertension. New York: John Wiley, 1977.

    Google Scholar 

  4. Edwards JE. Functional pathology of the pulmonary vascular tree in congenital cardiac disease. Circulation 15: 164–196. 1957.

    PubMed  CAS  Google Scholar 

  5. Fineberg MH, Wiggers CJ. Compensation and failure of the right ventricle. Am Heart J 11: 225–263. 1936.

    Google Scholar 

  6. Braunwild E, Ross J, Sonnenblick EH. Mechanisms of Contraction of the Normal and Failing Heart. Boston: Little, Brown. 1976.

    Google Scholar 

  7. Moser KM. Pulmonary embolism. Am Rev Respir Dis 115: 829–852, 1977.

    PubMed  CAS  Google Scholar 

  8. Mack I, Harris R, Katz LN. Acute cor pulmonale in the absence of pulmonary embolism. Am Heart J 39: 664–677, 1950.

    PubMed  CAS  Google Scholar 

  9. Altemus LR, Lee RE. Carcinomatosis of the lung with pulmonary hypertension. Arch Int Med 119: 32–38, 1967.

    CAS  Google Scholar 

  10. Brill IC, Robertson TD. Subacute cor pulmonale. Arch Int Med 60: 1043–1057, 1937.

    Google Scholar 

  11. Kane RD, Hawkins HK, Miller JA, Noce PS. Microscopic pulmonary tumor emboli associated with dyspnea. Cancer 36: 1473–1482, 1975.

    PubMed  CAS  Google Scholar 

  12. Morgan AD. The pathology of subacute cor pulmonale in diffuse carcinomatosis of the lungs. J Path Bact 61: 75–84, 1949.

    Google Scholar 

  13. Winterbauer RH, Elfenbein IB, Ball WC. Incidence and clinical significance of tumor embolization to the lungs. Am J Med 45: 271–290, 1968.

    PubMed  CAS  Google Scholar 

  14. Bank L. Benatar SR. Subacute cor pulmonale in hypersensitivity pneumonitis. A case report. S Afr Med J 62: 768–769, 1982.

    PubMed  CAS  Google Scholar 

  15. Brenner O. Pathology of the vessels of the pulmonary circulation. Arch Int Med 56: 211–237, 457–497. 724–752, 976–1014, 1189–1241, 1935.

    Google Scholar 

  16. Weibel ER, Gomez DM. Architecture of the human lung. Science 137: 577–585, 1962.

    PubMed  CAS  Google Scholar 

  17. Reid LM. The pulmonary circulation: Remodeling in growth and disease. Am Rev Respir Dis 119: 531–546, 1979.

    PubMed  CAS  Google Scholar 

  18. Elliott FM, Reid L. Some new facts about the pulmonary artery and its brandling pattern. Clin Radiol 16: 193–198, 1965.

    PubMed  CAS  Google Scholar 

  19. Semmens M, Reid L. Pulmonary arterial muscularity and right ventricular hypertrophy in chronic bronchitis and emphysema. Br J Dis Chest 68: 253–263, 1974.

    PubMed  CAS  Google Scholar 

  20. Harris P, Heath D. The Human Pulmonary Circulation. Edinburgh: Churchill Livingstone, 1977.

    Google Scholar 

  21. Heath D, Best PV. The tunica medica of the arteries of the lung in pulmonary hypertension. J Path Bact 76: 165–174, 1958.

    PubMed  CAS  Google Scholar 

  22. Katzenstein AL, Askin FB. Surgical Pathology of Non-neoplastic Lung Disease. Major Problems in Pathology Series (Volume 13). Philadelphia: W.B. Saunders, 1982, pp. 281–313.

    Google Scholar 

  23. Civin WH, Edwards JE. The postnatal structural changes in the intrapulmonary arteries and arterioles. Arch Path 51: 192–200, 1951.

    CAS  Google Scholar 

  24. Reid A, Heard BE. Preliminary studies of human pulmonary capillaries by India ink injection. Med Thorac 19: 215–219, 1962.

    PubMed  CAS  Google Scholar 

  25. Cudkowicz L. Bronchial arterial circulation in man. Normal anatomy and responses to disease. In Pulmonary Vascular Diseases, Moser KM (ed). New York: Marcel Dekker, 1979, pp. 111–232.

    Google Scholar 

  26. Wagenvoort CA, Neufield HN, Edwards JE. The structure of the pulmonary arterial tree in fetal and early postnatal life. Lab Invest 10: 751–762, 1961.

    PubMed  CAS  Google Scholar 

  27. Naeye RL. Arterial changes during the perinatal period. Arch Path 71: 121–128, 1961.

    PubMed  CAS  Google Scholar 

  28. Rudolph AM. The changes in the circulation after birth. Their importance in congenital heart disease. Circulation 41: 343–354, 1970.

    PubMed  CAS  Google Scholar 

  29. Simons P, Reid L. Muscularity of pulmonary artery branches in the upper and lower lobes of the normal young and aged lung. Br J Dis Chest 63: 38–44, 1969.

    PubMed  CAS  Google Scholar 

  30. Wagenvoort CA, Wagenvoort N. Age changes in muscular pulmonary arteries. Arch Path 79: 524–528, 1965.

    PubMed  CAS  Google Scholar 

  31. Warnock ML, Kunzmann A. Changes with age in muscular pulmonary arteries. Arch Path Lab Med 101: 175–179, 1977.

    PubMed  CAS  Google Scholar 

  32. West JB, Dollery CT, Heard BE. Increased pulmonary vascular resistance in the dependent zone of the isolated dog lung caused by perivascular edema. Circ Res 17: 191–206, 1965.

    PubMed  Google Scholar 

  33. Auerbach O, Stout AP, Hammond EC, Garfinkel L. Smoking habits and age in relation to pulmonary changes. Rupture of alveolar septums, fibrosis and thickening of walls of small arteries and arterioles. N Engl J Med 269: 1045–1054. 1963.

    PubMed  CAS  Google Scholar 

  34. Naeye RL, Dellinger WS. Pulmonary arterial changes with age and smoking. Arch Path 92: 284–288, 1971.

    PubMed  CAS  Google Scholar 

  35. Hale KA, Niewoehner DE, Cosio MG. Morphologic changes in the muscular pulmonary arteries. Relationship to cigarette smoking, airway disease, and emphysema. Am Rev Respir Dis 122: 273–278, 1980.

    PubMed  CAS  Google Scholar 

  36. Wagenvoort CA, Wagenvoort N. Pulmonary arteries in bronchial carcinoma. Arch Path 79: 529–533, 1965.

    PubMed  CAS  Google Scholar 

  37. Wagenvoort CA. Morphologic changes in intrapulmonary veins. Human Path 1: 205–213, 1970.

    CAS  Google Scholar 

  38. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease. A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 18: 533–547, 1958.

    PubMed  CAS  Google Scholar 

  39. Heath D, Whitaker W. The pulmonary vessels in patent ductus arteriosus. J Path Bact 70: 285–290. 1955.

    PubMed  CAS  Google Scholar 

  40. Edwards JE. Pathology of chronic pulmonary hypertension. In Pulmonary Pathology Decennial. Sommers SC (ed). New York: Appleton-Century-Crofts, 1975, pp. 489–513.

    Google Scholar 

  41. Edwards WD, Edwards JE. Recent advances in the pathology of the pulmonary vasculature. In The Lung. Structure, Function and Diseases, Thurlbeck WM, Abell MR (eds). Baltimore; Williams & Wilkins, 1978, pp. 235–261.

    Google Scholar 

  42. Naeye RL. Pulmonary hypertension and vascular disease. In The Heart. Edwards JE. Lev M. Abell MR (eds). Baltimore: Williams & Wilkins. 1974, pp. 297–326.

    Google Scholar 

  43. Ramirez A, Grimes ET, Abelmann WH. Regression of pulmonary vascular changes following mitral valvuloplasty. An anatomic and physiologic case study. Am J Med 45: 975–982, 1968.

    PubMed  CAS  Google Scholar 

  44. Dalen JE, Matloff JM, Evans GL, Hoppin FG, Bhardwaj P, Harken DE, Dexter L. Early reduction of pulmonary vascular resistance after mitral valve replacement. N Engl J Med 277: 387–394. 1967.

    PubMed  CAS  Google Scholar 

  45. Goodale F, Sanchez G, Friedlich AC, Scannell JG, Myers GS. Correlation of pulmonary arteriolar resistance with pulmonary vascular changes in patients with mitral stenosis before and after valvulotomy. N Engl J Med 252: 979–983, 1955.

    PubMed  Google Scholar 

  46. Heath D, Smith P. Pulmonary vascular disease. Med Clin N Am 61: 1279–1307, 1977.

    PubMed  CAS  Google Scholar 

  47. Wagenvoort CA. Grading of pulmonary vascular lesions—A reappraisal. Histopathology 5: 595–598, 1981.

    PubMed  CAS  Google Scholar 

  48. Lamb D, Cor pulmonale and pulmonary hypertension. In The Pathology of the Heart, Pomerance A, Davies MJ (eds). Oxford; Blackwell Scientific Publications, 1975. pp. 167–198.

    Google Scholar 

  49. Fishman AP. Plexiform lesions. Path Microbiol 43: 242–245. 1975.

    CAS  Google Scholar 

  50. Ruttner JR, Bartschi P, Niederman R, Schneider J. Plexogenic pulmonary arteriopathy and liver cirrhosis. Thorax 35: 133–136, 1980.

    PubMed  CAS  Google Scholar 

  51. Saldana ME, Harley RA, Liebow AA, Carrington CB. Experimental extreme pulmonary hypertension and vascular disease in relation to polycythemia. Am J Path 52: 935–981, 1968.

    PubMed  CAS  Google Scholar 

  52. Wagenvoort CA. Classification of pulmonary vascular lesions in congenital and acquired heart disease. Adv in Cardiol 11: 48–55. 1974.

    CAS  Google Scholar 

  53. Wagenvoort CA. Hypertensive pulmonary vascular disease complicating congenital heart disease. A review. Cardiovasc Clinics 5: 43–60. 1973.

    CAS  Google Scholar 

  54. Yamaki S, Wagenvoort CA. Plexogenic pulmonary arteriopathy. Significance of medial thickness with respect to advanced pulmonary vascular lesions. Am J Path 105: 70–75, 1981.

    PubMed  CAS  Google Scholar 

  55. Wagenvoort CA. Classifying pulmonary vascular diseases. Chest 64: 503–504, 1973.

    PubMed  CAS  Google Scholar 

  56. Haworth SG, Reid L. A morphometric study of regional variation in lung structure in infants with pulmonary hypertension and congenital cardiac defects. Brit Heart J 40: 825–831, 1978.

    PubMed  CAS  Google Scholar 

  57. Haworth SG, Sauer U, Buhlmeyer K, Reid L. Development of the pulmonary circulation in ventricular septal defect. A quantitative structural study. Am J Cardiol 40: 781–788, 1977.

    PubMed  CAS  Google Scholar 

  58. Rabinovitch M, Haworth SG, Vance Z, Vawter G, Castaneda AR, Nadas AS, Reid LM. Early pulmonary vascular changes in congenital heart disease studied in biopsy tissue. Human Path 11: 499–509. 1980.

    CAS  Google Scholar 

  59. Wagenvoort CA. Vasoconstriction and medial hypertrophy in pulmonary hypertension. Circulation 22: 535–546. 1960.

    PubMed  CAS  Google Scholar 

  60. Wagenvoort CA. Lung biopsy specimens in the evaluation of pulmonary vascular disease. Chest 77: 615–625. 1980.

    Google Scholar 

  61. Rabinovitch M, Haworth SG, Castaneda AR, Nadas A, Reid L. Lung biopsy in congenital heart disease. A morphological approach to pulmonary vascular disease. Circulation 58: 1107–1122, 1978.

    PubMed  CAS  Google Scholar 

  62. Takahashi T, Wagenvoort CA. Density of muscularized arteries in the lung. Its role in congenital heart disease and its clinical significance. Arch Path Lab Med 107: 23–28, 1983.

    PubMed  CAS  Google Scholar 

  63. Takahashi T, Wagenvoort N, Wagenvoort CA. The density of muscularized pulmonary arteries in normal lungs. Arch Path Lab Med 107: 19–22, 1983.

    PubMed  CAS  Google Scholar 

  64. Fishman AP. Pulmonary Diseases and Disorders. New York: McGraw-Hill, 1982, pp. 863–882.

    Google Scholar 

  65. Anderson EG, Simons G, Reid L. Primary and thromboembolic pulmonary hypertension. A quantitative pathological study. J Path 110: 273–293, 1973.

    Google Scholar 

  66. Wagenvoort CA, Wagenvoort N. Primary pulmonary hypertension. A pathologic study of the lung vessels in 156 clinically diagnosed cases. Circulation 42: 1163–1183, 1970.

    Google Scholar 

  67. Glenn WWL, Liebow AA, Lindskog GE. Pulmonary vascular changes in congenital heart diseases. In Thoracic and Cardiovascular Surgery with Related Pathology. New York: Appleton-Century-Crofts, 1975, pp. 918–937.

    Google Scholar 

  68. World Health Organization. Primary Pulmonary Hypertension. Report of a WHO Meeting, October 15–17, 1973. Hatano S, Strasser T (eds), 1975, pp. 7–45.

    Google Scholar 

  69. Levine OR, Harris RC, Blanc WA, Mellins RB. Progressive pulmonary hypertension in children with portal hypertension. J Ped 83: 964–972, 1973.

    CAS  Google Scholar 

  70. Naeye RL. Primary pulmonary hypertension with coexisting portal hypertension. A retrospective study of six cases. Circulation 22: 376–384, 1960.

    PubMed  CAS  Google Scholar 

  71. Segel N, Kay JM, Bayley TJ, Paton A. Pulmonary hypertension with hepatic cirrhosis. Br Heart J 30: 575–578, 1968.

    PubMed  CAS  Google Scholar 

  72. Senior RM, Britton RC, Turino GM, Wood JA, Langer GA, Fishman AP. Pulmonary hypertension associated with cirrhosis of the liver and with portacaval shunts. Circulation 37: 88–96, 1968.

    PubMed  CAS  Google Scholar 

  73. Morrison EB, Gaffney FA, Eigenbrodt EH, Reynolds RC, Buja LM. Severe pulmonary hypertension associated with macronodular (postnecrotic) cirrhosis and autoimmune phenomena. Am J Med 69: 513–519, 1980.

    PubMed  CAS  Google Scholar 

  74. Cohen MD, Rubin LJ, Taylor WE, Cuthbert JA. Primary pulmonary hypertension. A unique case associated with extrahepatic portal hypertension. Hepatology 3: 588–592, 1983.

    PubMed  CAS  Google Scholar 

  75. Fishman AL. Dietary pulmonary hypertension. Circ Res 35: 657–660. 1964.

    Google Scholar 

  76. Gorham LW. A study of pulmonary embolism. Arch Int Med 108: 8–22, 189–207, 418–426, 1961.

    CAS  Google Scholar 

  77. Hampton AO, Castleman B. Correlation of postmortem chest teleroentgenograms with autopsy findings. Am J Roentgenol 43: 305–325, 1940.

    Google Scholar 

  78. Korn D, Gore I, Blenke A, Collins DP. Pulmonary arterial bands and webs. An unrecognized manifestation of organized pulmonary emboli. Am J Path 40: 129–151, 1962.

    PubMed  CAS  Google Scholar 

  79. Edwards WD, Edwards JE. Clinical primary pulmonary hypertension. Three pathologic types. Circ 56: 884–888, 1977.

    CAS  Google Scholar 

  80. Sadigursky M, Andrade ZA. Pulmonary changes in schistosomal cor pulmonale. Am J Trop Med Hyg 31: 779–784, 1982.

    PubMed  CAS  Google Scholar 

  81. Roffman BY, Simons M. Syncytial trophoblastic embolism associated with placenta increta and pre-eclampsia. Am J Ob Gyn 104: 1218–1220, 1969.

    CAS  Google Scholar 

  82. Warren S. Fat embolism. Am J Path 22: 69–87, 1946.

    Google Scholar 

  83. Schinella RA. Bone marrow emboli. Arch Path 95: 386–391, 1973.

    PubMed  CAS  Google Scholar 

  84. Rappaport H, Raum M, Horrell JB. Bone marrow embolism. Am J Path 27: 407–433, 1951.

    PubMed  CAS  Google Scholar 

  85. Tomashefski JF, Hirsch CS. The pulmonary vascular lesions of intravenous drug abuse. Human Path 11: 133–145, 1980.

    Google Scholar 

  86. Arnett EN, Battle WE, Russo JV, Roberts WC. Intravenous injection of talc-containing drugs intended for oral use. Am J Med 60: 711–718, 1976.

    PubMed  CAS  Google Scholar 

  87. Lewman LV. Fatal pulmonary hypertension from intravenous injection of methylphenidate (Ritalin) tablets. Human Path 3: 67–70, 1972.

    CAS  Google Scholar 

  88. Robertson CH, Reynolds RC, Wilson JE. Pulmonary hypertension and foreign body granulomas in intravenous drug abusers. Documentation by cardiac catheterization and lung biopsy. Am J Med 61: 657–664, 1976.

    PubMed  Google Scholar 

  89. Sturner WQ, Spruill FG, Garriott JC. Two propylhexedrine-associated fatalities. Benzedrine revisited. J Forensic Sci 19: 572–574, 1974.

    PubMed  CAS  Google Scholar 

  90. Taylor WE, Cohle S. Personal observations.

    Google Scholar 

  91. Parker F, Weiss S. Nature and significance of structural changes in the lungs in mitral stenosis. Am J Path 12: 573–598, 1936.

    PubMed  CAS  Google Scholar 

  92. Andrews EC. Five cases of an undescribed form of pulmonary interstitial fibrosis caused by obstruction of the pulmonary veins. Bull Johns Hopkins Hosp 100: 28–42, 1957.

    PubMed  Google Scholar 

  93. Goodwin RA, Nickell JA, Des Prez RM. Mediastinal fibrosis complicating healed pulmonary histoplasmosis and tuberculosis. Medicine 51: 227–246, 1972.

    PubMed  CAS  Google Scholar 

  94. Wagenvoort CA. Pulmonary veno-occlusive disease. Entity or syndrome? Chest 69: 82–86, 1976.

    PubMed  CAS  Google Scholar 

  95. McDonnell PJ, Summer WR, Hutchins GM. Pulmonary veno-occlusive disease. Morphological changes suggesting a viral cause. JAMA 246: 667–671, 1981.

    PubMed  CAS  Google Scholar 

  96. Carrington CB, Liebow AA. Pulmonary veno-occlusive disease. Human Path 1: 322–324, 1970.

    CAS  Google Scholar 

  97. Crissman JD, Koss M, Carson RP. Pulmonary veno-occlusive disease secondary to granulomatous venulitis. Am J Surg Path 4: 93–99, 1980.

    PubMed  CAS  Google Scholar 

  98. Arias-Stella J, Saldana M. The terminal portion of the pulmonary arterial tree in people native to high altitude. Circulation 28: 915–925, 1963.

    PubMed  CAS  Google Scholar 

  99. Amad KH, Brennan JC, Alexander JK. The cardiac pathology of chronic exogenous obesity. Circulation 32: 740–745, 1965.

    PubMed  CAS  Google Scholar 

  100. Bergofsky EH, Turino GM, Fishman AP. Cardiorespiratory failure in kyphoscoliosis. Medicine 38: 263–317. 1959.

    PubMed  CAS  Google Scholar 

  101. Turino GM, Goldring RM, Fishman AP. Cor pulmonale in musculoskeletal abnormalities of the thorax. Bull NY Acad Med 41: 959–980, 1965.

    CAS  Google Scholar 

  102. Levine OR, Simpser M. Alveolar hypoventilation and cor pulmonale associated with chronic airway obstruction in infants with Down’s syndrome. Clin Pediatr 21: 25–28, 1982.

    CAS  Google Scholar 

  103. Naeye RL. Alveolar hypoventilation and cor pulmonale secondary to damage to the respiratory center. Am J Cardiol 8: 416–419, 1961.

    PubMed  CAS  Google Scholar 

  104. Hicken P, Health D, Brewer DB, Whitaker W. The small pulmonary arteries in emphysema. J Path Bact 90: 107–114, 1965.

    PubMed  CAS  Google Scholar 

  105. Moss AJ. The cardiovascular system in cystic fibrosis. Pediatrics 70: 728–741, 1982.

    PubMed  CAS  Google Scholar 

  106. Heath D. Longitudinal muscle in pulmonary arteries. J Path Bact 85: 407–412, 1963.

    Google Scholar 

  107. Hasleton PS, Health D, Brewer DB. Hypertensive pulmonary vascular disease in states of chronic hypoxia. J Path Bact 95: 431–140, 1968.

    PubMed  CAS  Google Scholar 

  108. Heath D, Smith P. Pulmonary vascular disease secondary to lung disease. In Pulmonary Vascular Diseases. Moser KM (ed). New York: Marcel Dekker, 1979, pp. 387–126.

    Google Scholar 

  109. Hicken P, Heath D, Brewer DB. The relation between the weight of the right ventricle and the percentage of abnormal air space in the lung in emphysema. J Path Bact 92: 519–528, 1966.

    PubMed  CAS  Google Scholar 

  110. Hicken P, Brewer DB, Heath D. The relation between the weight of the right ventricle of the heart and the internal surface area and number of alveoli in the human lung in emphysema. J Path Bact 92: 529–546, 1966.

    PubMed  CAS  Google Scholar 

  111. Millard J, Reid L. Right ventricular hypertrophy and its relationship to chronic bronchitis and emphysema. Brit J Dis Chest 68: 103–110, 1974.

    PubMed  CAS  Google Scholar 

  112. Wagenvoort CA, Nauta J, van der Schaar PJ, Weeda HWH, Wagenvoort N. Vascular changes in pulmonic stenosis and tetralogy of Fallot in lung biopsies. Circulation 36: 924–932, 1967.

    PubMed  CAS  Google Scholar 

  113. Wagenvoort CA, Nauta J, van der Schaar PJ, Weeda HWH, Wagenvoort N. The pulmonary vasculature in complete transposition of the great vessels judged from lung biopsies. Circulation 38: 746–754, 1968.

    PubMed  CAS  Google Scholar 

  114. Wagenvoort CA, Wagenvoort N. Pulmonary vascular bed. Normal anatomy and responses to disease. In Lung Biology in Health and Disease, Moser K (ed). New York: Marcel Dekker, 1979, pp. 1–109.

    Google Scholar 

  115. Rich AR. A hitherto unrecognized tendency to the development of widespread pulmonary vascular obstruction in patients with congenital pulmonary stenosis (tetralogy of Fallot). Bull Johns Hopkins Hosp 82: 389–401, 1948.

    PubMed  CAS  Google Scholar 

  116. Hecht HW. Heart failure and lung disease. Circulation 14: 265–290, 1956.

    PubMed  CAS  Google Scholar 

  117. Reiner L, Mazzoleni A, Rodgiruez FL, Freudenthal RR. The weight of the human heart I. Normal cases. Arch Path 68: 58–73, 1959.

    CAS  Google Scholar 

  118. Reiner L, Mazzoleni A, Rodriguez FL, Freudenthal RR. The weight of the human heart. II. Hypertensive cases. Arch Path 71: 180–201, 1961.

    PubMed  CAS  Google Scholar 

  119. Fulton RM, Hutchinson EC, Jones AM. Ventricular weight in cardiac hypertrophy. Br Heart J 14: 413–420, 1952.

    PubMed  CAS  Google Scholar 

  120. Lambert RA, Allison BR. Types of lesion in chronic passive congestion of the liver. Bull Johns Hopkins Hosp 27: 350–356, 1916.

    Google Scholar 

  121. Moschowitz E. The morphology and pathogenesis of cardiac fibrosis of the liver. Ann lnt Med 36: 933–955, 1952.

    Google Scholar 

  122. Von Glahn WC, Chobot R. The histological alterations of the pancreas in chronic passive congestion. Am J Path 1: 373–381, 1925.

    Google Scholar 

  123. Shuck JW, Walder JS, Kam TH, Thomas HM. Chronic persistent pulmonary embolism. Report of three cases. Am J Med 69: 790–794, 1980.

    PubMed  CAS  Google Scholar 

  124. Rubin LJ, Peter RH. Oral hydralazine therapy for primary pulmonary hypertension. N Engl J Med 302: 69–73, 1980.

    PubMed  CAS  Google Scholar 

  125. Abraham JL, Brambilla C. Particle size for differentiation between inhalation and injection pulmonary talcosis. Environ Res 21: 94–96, 1980.

    PubMed  CAS  Google Scholar 

  126. Gaensler EA, Carrington CB. Open biopsy for chronic diffuse infiltrative lung disease. Clinical, radiologic-physiologic correlations in 502 cases. Ann Thor Surg 30: 411–426, 1980.

    CAS  Google Scholar 

Download references

Authors
  1. Wayne E. Taylor M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Texas Health Science Center at Dallas, Dallas, TX, USA

    Lewis J. Rubin M.D. (Assistant Professor of Internal Medicine Chief) (Assistant Professor of Internal Medicine Chief)

  2. Pulmonary Section, Veterans Administration Medical Center, Dallas, TX, USA

    Lewis J. Rubin M.D. (Assistant Professor of Internal Medicine Chief) (Assistant Professor of Internal Medicine Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Martinus Nijhoff Publishing

About this chapter

Cite this chapter

Taylor, W.E. (1984). Pathology of Pulmonary Heart Disease. In: Rubin, L.J. (eds) Pulmonary Heart Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2847-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2847-6_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9797-0

  • Online ISBN: 978-1-4613-2847-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation